Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita T Y Lee

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Rheumatology|March 3, 2005
Reactive joint symptoms following an outbreak of Salmonella typhimurium phage type 135aAnita T Y Lee, Robert G Hall, Kevin D Pile
The Journal of Rheumatology|July 17, 2016
Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis CohortNasir T Wabe, Michael J Sorich, Mihir D Wechalekar, et al.
Seminars in Arthritis and Rheumatism|March 30, 2007
Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug useSusanna M Proudman, Helen I Keen, Lisa K Stamp, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Rheumatology|March 3, 2005
Reactive joint symptoms following an outbreak of Salmonella typhimurium phage type 135aAnita T Y Lee, Robert G Hall, Kevin D Pile
The Journal of Rheumatology|July 17, 2016
Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis CohortNasir T Wabe, Michael J Sorich, Mihir D Wechalekar, et al.
Seminars in Arthritis and Rheumatism|March 30, 2007
Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug useSusanna M Proudman, Helen I Keen, Lisa K Stamp, et al.
Pageof 1